Skip to main content

Table 3 Linear regression analysis between glucose metabolism and FIB in patients with DM, without DM and whole

From: Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study

Variable

Adjusted R square

Coefficient

95% CI

SEM

P value

Whole

 HbA1C, %

0.016

0.137

0.027 to 0.158

0.939

0.005

 FBG, mmol/L

0.017

0.138

0.016 to 0.092

0.939

0.005

DM

 HbA1C, %

0.035

0.210

0.009 to 0.212

0.781

0.009

 FBG, mmol/L

0.029

0.197

0.001 to 0.098

0.784

0.046

Non-DM

 HbA1c, %

− 0.001

0.052

− 0.157 to 0.423

0.989

0.367

 FBG, mmol/L

0.001

0.063

− 0.035 to 0.126

0.988

0.267

  1. FIB fibrinogen, DM diabetes mellitus, HbA1c Hemoglobin A1c, FBG fasting blood glucose, CI confidence interval, SEM standard error of measurement
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840